Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.

Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.
Indian lawmakers are currently debating amendments that would make it easier for foreign investors to develop products from native biological resources.
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.